{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:31:53Z","timestamp":1783420313017,"version":"3.54.6"},"reference-count":11,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"4","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2021,4,21]]},"DOI":"10.1167\/tvst.10.4.23","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T11:54:40Z","timestamp":1619092480000},"page":"23","source":"Crossref","is-referenced-by-count":13,"title":["Tackling the Challenges of Product Development Through a Collaborative Rare Disease Network: The Foundation Fighting Blindness Consortium"],"prefix":"10.1167","volume":"10","author":[{"given":"Todd A.","family":"Durham","sequence":"first","affiliation":[{"name":"Foundation Fighting Blindness, Columbia, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacque L.","family":"Duncan","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison R.","family":"Ayala","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Birch","sequence":"additional","affiliation":[{"name":"Retina Foundation of the Southwest, Dallas, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet K.","family":"Cheetham","sequence":"additional","affiliation":[{"name":"Foundation Fighting Blindness, Columbia, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Frederick L.","family":"Ferris","sequence":"additional","affiliation":[{"name":"Ophthalmic Research Consultants, Waxhaw, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel B.","family":"Hoyng","sequence":"additional","affiliation":[{"name":"Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Pennesi","sequence":"additional","affiliation":[{"name":"Casey Eye Institute \u2013 Oregon Health & Science University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Alain","family":"Sahel","sequence":"additional","affiliation":[{"name":"Institut de la Vision, Sorbonne Universit\u00e9, INSERM, CNRS, Paris, France"},{"name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC1423, Paris, France"},{"name":"Department of Ophthalmology, The University of Pittsburgh School of Medicine, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Foundation Fighting Blindness Consortium Investigator Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib2","doi-asserted-by":"publisher","first-page":"368rv366","DOI":"10.1126\/scitranslmed.aaf2838","article-title":"Emerging therapies for inherited retinal degeneration","volume":"8","author":"Scholl","year":"2016","journal-title":"Sci Transl Med"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.7.4.6","article-title":"Inherited retinal degenerations: current landscape and knowledge gaps","volume":"7","author":"Duncan","year":"2018","journal-title":"Transl Vis Sci Technol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/tvst.9.7.2","article-title":"Advancing clinical trials for inherited retinal diseases: recommendations from the Second Monaciano Symposium","volume":"9","author":"Thompson","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/jamaophthalmol.2018.1171","article-title":"Effect of oral valproic acid vs placebo for vision loss in patients with autosomal dominant retinitis pigmentosa: a randomized phase 2 multicenter placebo-controlled clinical trial","volume":"136","author":"Birch","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/jamaophthalmol.2016.0502","article-title":"Quantification of ellipsoid zone changes in retinitis pigmentosa using en face spectral domain\u2013optical coherence tomography","volume":"134","author":"Hariri","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/tvst.8.2.16","article-title":"A workshop on measuring the progression of atrophy secondary to Stargardt disease in the ProgStar Studies: findings and lessons learned","volume":"8","author":"Ervin","year":"2019","journal-title":"Transl Vis Sci Technol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaophthalmol.2020.1735","article-title":"Longitudinal microperimetric changes of macular sensitivity in Stargardt disease after 12 months: ProgStar Report No. 13","volume":"138","author":"Sch\u00f6nbach","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamaophthalmol.2019.2885","article-title":"Progression of Stargardt disease as determined by fundus autofluorescence over a 12-month period: ProgStar Report No. 11","volume":"137","author":"Strauss","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1001\/jamaophthalmol.2018.2198","article-title":"Visual acuity change over 24 months and its association with foveal phenotype and genotype in individuals with Stargardt disease: ProgStar Study Report No. 10","volume":"136","author":"Kong","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/ajmg.c.v184.3","article-title":"Implementation of a registry and open access genetic testing program for inherited retinal diseases within a non-profit foundation","volume":"184","author":"Mansfield","year":"2020","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"bib1","article-title":"Cost of Illness Study: US & Canada.","year":"2020"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2772503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T11:54:42Z","timestamp":1619092482000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2772503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.10.4.23","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,21]]}}}